Cargando…
PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN MYELODYSPLASTIC SYNDROME?-REAL WORLD DATA FROM HUNGARY
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428984/ http://dx.doi.org/10.1097/01.HS9.0000850548.60681.40 |
| _version_ | 1784779290878935040 |
|---|---|
| author | Miltényi, Z. Dr Gál, A. E. Tóthfalusi, D. Prof Dr Illés, Á. |
| author_facet | Miltényi, Z. Dr Gál, A. E. Tóthfalusi, D. Prof Dr Illés, Á. |
| author_sort | Miltényi, Z. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9428984 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94289842022-08-31 PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN MYELODYSPLASTIC SYNDROME?-REAL WORLD DATA FROM HUNGARY Miltényi, Z. Dr Gál, A. E. Tóthfalusi, D. Prof Dr Illés, Á. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428984/ http://dx.doi.org/10.1097/01.HS9.0000850548.60681.40 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Miltényi, Z. Dr Gál, A. E. Tóthfalusi, D. Prof Dr Illés, Á. PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN MYELODYSPLASTIC SYNDROME?-REAL WORLD DATA FROM HUNGARY |
| title | PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN MYELODYSPLASTIC SYNDROME?-REAL WORLD DATA FROM HUNGARY |
| title_full | PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN MYELODYSPLASTIC SYNDROME?-REAL WORLD DATA FROM HUNGARY |
| title_fullStr | PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN MYELODYSPLASTIC SYNDROME?-REAL WORLD DATA FROM HUNGARY |
| title_full_unstemmed | PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN MYELODYSPLASTIC SYNDROME?-REAL WORLD DATA FROM HUNGARY |
| title_short | PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN MYELODYSPLASTIC SYNDROME?-REAL WORLD DATA FROM HUNGARY |
| title_sort | pb1924: are we taking advantage of therapeutic options in myelodysplastic syndrome?-real world data from hungary |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428984/ http://dx.doi.org/10.1097/01.HS9.0000850548.60681.40 |
| work_keys_str_mv | AT miltenyiz pb1924arewetakingadvantageoftherapeuticoptionsinmyelodysplasticsyndromerealworlddatafromhungary AT drgalae pb1924arewetakingadvantageoftherapeuticoptionsinmyelodysplasticsyndromerealworlddatafromhungary AT tothfalusid pb1924arewetakingadvantageoftherapeuticoptionsinmyelodysplasticsyndromerealworlddatafromhungary AT profdrillesa pb1924arewetakingadvantageoftherapeuticoptionsinmyelodysplasticsyndromerealworlddatafromhungary |